LLY Company Profile and Key Details
Eli Lilly and Company
LLY Stock Price Chart
Stock Price Today
Eli Lilly and Company (LLY) stock surged +1.93%, trading at $826.07 on NYSE, up from the previous close of $810.43. The stock opened at $811.05, fluctuating between $805.94 and $829.00 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Company Information
| Employees | 43000 |
| Beta | 0.43 |
| Sales or Revenue | $34.12B |
| 5Y Sales Change% | 0.814% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
Frequently Asked Questions
Eli Lilly and Company (NYSE: LLY) stock price is $826.07 in the last trading session. During the trading session, LLY stock reached the peak price of $829.00 while $805.94 was the lowest point it dropped to. The percentage change in LLY stock occurred in the recent session was 1.93% while the dollar amount for the price change in LLY stock was $15.64.
The NYSE listed LLY is part of Drug Manufacturers - General industry that operates in the broader Healthcare sector. Eli Lilly and Company designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Jacob S. Van Naarden
Senior Vice President, Chief Executive Officer of Loxo Oncology & Pres of Lilly Oncology
Mr. Donald A. Zakrowski
Chief Accounting Officer & Vice President of Fin.
Ms. Leigh Ann Pusey
Executive Vice President of Corporation Affairs & Communications
Mr. Alonzo Weems
EVice President of Enterprise Risk Management and Chief Ethics & Compliance Officer
Mr. Patrik Jonsson
EVice President, Chief Customer Officer, Pres of Lilly USA & Lilly Immunology
Mr. Eric Dozier
Executive Vice President of HR & Diversity
Dr. Daniel M. Skovronsky M.D., Ph.D.
Executive Vice President, Chief Scientific & Medical Officer and Pres of Lilly Research Laboratories
Mr. Martin Bott MIBS
Vice President of Fin. & Special Projects
Mr. Diogo Rau
EVice President & Chief Information and Digital Officer
Ms. Anat Ashkenazi
Executive Vice President & Chief Financial Officer
Ms. Anat Hakim J.D.
Executive Vice President, Gen. Counsel & Sec.
Mr. David A. Ricks
Chairman, Chief Executive Officer & Pres
LLY's closing price is 19.53% higher than its 52-week low of $691.10 where as its distance from 52-week high of $972.53 is -15.06%.
Number of LLY employees currently stands at 43,000.
Official Website of LLY is: https://www.lilly.com
LLY could be contacted at phone 317 276 2000 and can also be accessed through its website. LLY operates from Lilly Corporate Center, Indianapolis, IN 46285, United States.
LLY stock volume for the day was 2.99M shares. The average number of LLY shares traded daily for last 3 months was 3.96M.
The market value of LLY currently stands at $784.20B with its latest stock price at $826.07 and 949.32M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com